Chiracon GmbH

Own products (APIs) for the generic pharmaceutical industry.

We provide quality products and services, consistently,
reliably responsibly and continuously applying some of the world’s
most difficult to handle chemical technologies.
Our independent one-site,
single entity corporate setup enables


Synthesis: Manufacturing services and products for all user industries,
using Archimica´s highly differentiated setup and technologies
APIs, Building blocks, GMP intermediates, Regulatory Starting Materials
For all global markets including the United States of America,
in total Archimica products reach 25 countries.

For the total GMP synthesis of complex carbohydrates and carbohydrate based medicinal chemistry, Dextra has a proven record of developing innovative solutions to minimise costs, reduce technology transfer issues and optimise robust route generation.

Custom Synthesis—from mgs to multi kg scale, core capabilities include: Process development, glycosylation, hydrogenation and conjugation chemistry.

Analytical Services—providing comprehensive analytical support for custom synthesis programs and independent analytical services

GMP API Manufacturing—to support Phase I and Phase II clinical trials in reactors up to 50 L

Dextra Catalogue—showcases a range of over 800 carbohydrate products, including neoglycoproteins, neoglycolipids, heparin derivatives, iminosugars, blood group products, oligosaccharides, glycans, building blocks and a range of rare sugars for glycobiology and reference standards.

Dextra also has the ability to transfer complex chemical processes to its large scale manufacturing parent, New Zealand Pharmaceuticals.

@DextraLabs

Pepceuticals Limited, established in 1998, is a specialist British manufacturer of synthetic peptides. We remain dedicated to supplying the Life Science industry with high-quality custom peptides and an antibody manufacturing service. Over the years, Pepceuticals has established a reputation for excellence in the field of peptide synthesis, having developed novel technologies that allow us to prepare complex peptide molecules. We are committed to providing solutions to researchers globally by continuing to increase our development program of large and small synthetic peptide libraries, and enhancing the prospects of obtaining new research candidates.

We provide a comprehensive drug development program that allows us to furnish peptides manufactured under cGMP, from milligram to kilogram quantities and to support all aspects of peptide manufacture. Furthermore, we also have an active program to develop generic peptide active substances (API’s) that cover many different disease areas.

At Pepceuticals, we operate a stringent Pharmaceutical Quality System which verifies that the products we supply meet or exceed industry standards. Pepceuticals holds an API manufacturing licence as granted by the MHRA (Medicines and Healthcare Products Regulatory Agency) and BSI ISO 2001-2015 accreditation from the British Standards Industry (BSI) for our manufacturing practices. Our Quality Control (QC) team, ensure that our instrumentation, operating/ testing, and staff training are maintained and continually updated to achieve these high standards. Our aim is to deliver all our products in a reliable time frame with a full certificate of analysis and supporting data.

We ensure effective project management and good communication with all our clients; from sales to product delivery we aspire to offer a complete solution. We trust that you will enjoy the benefits of working with Pepceuticals, as a reliable, flexible and innovative peptide manufacturer.

Procos S.p.A. is a wholly owned subsidiary of the Japanese company, CBC Co. Ltd Group, specializing in the development, scale-up and production of Active Pharmaceutical Ingredients (APIs), advanced intermediates and related services for the pharmaceutical industry.

Our core business sectors include custom synthesis and Generic API manufacturing.
The manufacturing site is located in Cameri, Italy. This 110,000 sq. meter, cutting-edge multipurpose plant, fully designed under cGMP compliance, has been successfully audited and approved by the main regulatory authorities including AIFA, FDA and PMDA.

We are a locally rooted company yet part of an international network, with commercial offices in key strategic geographies.

AltaBioscience is recognised worldwide as a leading manufacturing and analysis laboratory providing synthesis of DNA and peptides and analysis of proteins and other biochemical molecules, to researchers in academia, pharmaceuticals and the food industry.

Certified to ISO/IEC 17025:2005 for amino acid analysis, protein sequencing and steroid analysis. ISO 9001:2008 for the laboratory as a whole, AltaBioscience is committed to supplying high-quality products and analytical services at competitive prices.

• Custom Peptide Synthesis
• Tags & Conjugations
• Amino Acid Analysis
• N-Terminal Edman Protein Sequencing
• DNA/Oligo Synthesis
• Custom Antibody Generation
• Circular Dichroism analysis
• HPLC and MS Analytical Testing